T. J. Walsh, E. J. Anaissie, D. W. Denning, et al., “Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America,” Clinical Infectious Diseases, Vol. 46, No. 3, 2008, pp. 327-360. http://dx.doi.org/10.1086/525258

has been cited by the following article:

• TITLE: A Report of 2 Cases of Disseminated Invasive Aspergillosis with Myocarditis in Immunocompromised Patients

  AUTHORS: Tetsuhiro Yoshino, Hiroko Nishida, Takashi Takita, Masanori Nemoto, Michihiro Sakauchi, Mami Hatano, Kazuyuki Koyama, Masao Hori, Katsuyuki Obara

  KEYWORDS: Invasive Aspergillosis; Myocarditis; Acute Myeloid Leukemia; Rheumatoid Arthritis

  JOURNAL NAME: Open Journal of Pathology, Vol.3 No.4, October 8, 2013

  ABSTRACT: Invasive aspergillosis is a life-threatening opportunistic infection that occurs most often in immunocompromised patients, especially those with either hematological malignancies treated with chemotherapy or in organ transplant recipients. Here, we report 2 cases of disseminated invasive aspergillosis with myocarditis proven pathologically by autopsy. These 2 cases occurred in immunocompromised patients: the first patient received chemotherapy for acute myeloid leukemia with myelodysplasia-related changes (AML-MRC); the second patient received methotrexate therapy for rheumatoid arthritis (RA). Invasive aspergillosis with myocarditis has high morbidity and mortality rates, therefore it is necessary to make prompt diagnosis and to start intensive treatments quickly.